SGLT Inhibitors Versus DDP4 Inhibitors and Prostate in Patient With Diabetes
NCT06148259 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 57
Last updated 2023-11-28
Summary
The study aims to compare the effect of two different classes of anti- diabetes medications on prostate volume and symptoms in elderly patients with diabetes mellitus
Conditions
- Diabetes Mellitus
- Prostatic Hyperplasia
Interventions
- OTHER
-
International prostate symptom score
Questionnaire of 8 questions to be administered to all patients about prostate symptoms
- DIAGNOSTIC_TEST
-
Assessment of prostate volume
Measurements using ultrasound
- OTHER
-
Pittsburgh sleep quality Index
Questionnaire to assess quality of sleep
- DIAGNOSTIC_TEST
-
Glycated hemoglobin
Measures control of diabetes
Sponsors & Collaborators
-
Kasr El Aini Hospital
lead OTHER
Principal Investigators
-
Tarek Abdelaziz · Cairo University Kasr Alainy Faculty of Medicine
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-03-12
- Primary Completion
- 2022-09-13
- Completion
- 2022-09-13
Countries
- Egypt
Study Locations
More Related Trials
-
Effectiveness of Glucose Control, β Cell Function in Response to Short-term Insulin Pump Therapy in Type 2 Diabetes
NCT03509324 ·Status: COMPLETED ·Phase: PHASE4
-
GA 6: The Blood Glucose-lowering Effect of Glucose-dependent Insulinotropic Polypeptide
NCT03845179 ·Status: COMPLETED ·Phase: NA
-
Effects of Prebiotics on GLP-1 in Type 2 Diabetes
NCT02569684 ·Status: COMPLETED ·Phase: NA
-
Paradoxical Stimulation of Hepatic Glucose Production With Dapagliflozin
NCT02984644 ·Status: COMPLETED ·Phase: PHASE3
-
The Effect of GLP-1 on the Inhibition of Glucagon Secretion
NCT01507597 ·Status: COMPLETED ·Phase: NA
-
Insulinotropic Effect of GIP and GLP-1 Before and After Reduced Glucose Tolerance
NCT01173978 ·Status: COMPLETED ·Phase: NA
-
Glycemic And Blood Pressure Control In Type 2 Diabetes, In A Primary Care Unit: A Staged Management Strategy
NCT00935805 ·Status: UNKNOWN
-
The Effect of GLP-1 on Postprandial Glucagon Secretion Independent of The Gastric Emptying Rate
NCT02584582 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
"Effect of Dipeptidyl Peptidase IV After Diets in näive Type 2 Diabetic Patients"
NCT00881543 ·Status: COMPLETED ·Phase: NA
-
Glucagon Like Peptide 1 Receptor (GLP1R) Expression and Beta-cell Mass in Patients With Type 2 Diabetes
NCT04733508 ·Status: UNKNOWN ·Phase: NA
-
The Beta Cell Responsiveness to Glucose-dependent Insulinotropic Polypeptide (GIP) With and Without Sulfonylurea in Patients With Type 2 Diabetes
NCT00321321 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Gastric Emptying on Blood Glucose Profile of Type 1 Diabetes Mellitus and Its Therapeutic Strategies
NCT06173934 ·Status: RECRUITING ·Phase: NA
-
Current Status of Islet Alpha Cell Function in Patients with Type 2 Diabetes
NCT06825182 ·Status: RECRUITING ·Phase: PHASE3
-
Clinical Application of an Open-source Artificial Pancreas System in Adult Inpatients With Diabetes
NCT05765097 ·Status: COMPLETED ·Phase: NA
-
Glucose-dependent Insulinotropic Polypeptide as a Safeguard Against Hypoglycemia in Patients With Type 1 Diabetes
NCT03556098 ·Status: COMPLETED ·Phase: NA
-
Characterizing the Incretin Effect of Amino Acids and Defining GLP-1 Role on Skeletal Muscle
NCT02370745 ·Status: COMPLETED ·Phase: NA
-
HbA1c Variability in Type II Diabetes
NCT02879409 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Albiglutide Glucose Clamp Study in Subjects With Type 2 Diabetes
NCT01475734 ·Status: COMPLETED ·Phase: PHASE2
-
GIP Receptor Antagonist Studies in Humans
NCT02747472 ·Status: COMPLETED ·Phase: NA
-
The Insulin Response to the Gut Hormone GIP After Near-normalisation of Plasma Glucose in Patients With Type 2 Diabetes
NCT04228484 ·Status: COMPLETED ·Phase: NA
-
Study of Comparison the Treatment Effect Between Gastric Bypass and Exenatide in Type 2 Diabetes
NCT01435980 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy of Domperidone (a Prokinetic Agent) on Time in Range in Digestively Asymptomatic Type I Diabetic Patients With Delayed Gastric Emptying (Gastro-TIR)
NCT06695962 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Relationship Between Improvement in Insulin Secretion and Decrease in HbA1c in GLP-1 RA Therapy in T2DM Patients
NCT04135287 ·Status: UNKNOWN ·Phase: PHASE4
-
Identification of Biometric Marker(s) Capable of Detecting Early Prediabetes: Clinical Trial 1
NCT04625088 ·Status: COMPLETED ·Phase: NA
-
Near Normalisation of BG Improves the Potentiating Effect of GLP-1
NCT00612625 ·Status: COMPLETED ·Phase: NA